Reactive oxygen homeostasis - The balance for preventing autoimmunity

Lupus

Volumn 25, Issue 8, 2016, Pages 943-954

  Kienhofer D ^a   Boeltz, S ^a   Hoffmann, M H ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

autoimmune diseases; NAPDH oxidase (NOX); oxidative stress; Reactive oxygen species (ROS); rheumatoid arthritis (RA); systemic lupus erythematosus (SLE)

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; B LYMPHOCYTE RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; LIPID; NUCLEIC ACID; PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CHRONIC DISEASE; CHRONIC GRANULOMATOUS DISEASE; GOUT; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MACROPHAGE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PSORIASIS; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SCAVENGING SYSTEM; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; ANIMAL; CLASSIFICATION; DISEASE MODEL; HOMEOSTASIS; IMMUNOLOGY; MOUSE; OXIDATION REDUCTION REACTION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; HOMEOSTASIS; HUMANS; MICE; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84973322884     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316640919     Document Type: Article

References (131)

1. Schauer C, Janko C, Munoz LE, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med 2014; 20: 511-517.
2. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R,. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 2004; 101: 12646-12651.
3. Campbell AM, Kashgarian M, Shlomchik MJ,. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci Transl Med 2012; 4: 157ra41-157ra41.
4. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176: 231-241.
5. Gelderman KA, Hultqvist M, Pizzolla A, et al. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest 2007; 117: 3020-3028.
6. Gomez-Guzman M, Jimenez R, Romero M, et al. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension 2014; 64: 330-337.
7. Hultqvist M, Backlund J, Bauer K, Gelderman KA, Holmdahl R,. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J Immunol 2007; 179: 1431-1437.
8. Jacob CO, Eisenstein M, Dinauer MC, et al. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci USA 2012; 109: E59-E67.
9. Kelkka T, Kienhofer D, Hoffmann M, et al. Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature. Antioxid Redox Signal 2014; 21: 2231-2245.
10. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, Holmdahl R,. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 2003; 33: 25-32.
11. Padgett LE, Burg AR, Lei W, Tse HM,. Loss of NADPH oxidase-derived superoxide skews macrophage phenotypes to delay type 1 diabetes. Diabetes 2015; 64: 937-946.
12. Thayer TC, Delano M, Liu C, et al. Superoxide production by macrophages and T cells is critical for the induction of autoreactivity and type 1 diabetes. Diabetes 2011; 60: 2144-2151.
13. Tse HM, Thayer TC, Steele C, et al. NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. J Immunol 2010; 185: 5247-5258.
14. Khmaladze I, Kelkka T, Guerard S, et al. Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Proc Natl Acad Sci USA 2014; 111: E3669-E3678.
15. Nathan C, Cunningham-Bussel A,. Beyond oxidative stress: An immunologist's guide to reactive oxygen species. Nat Rev Immunol 2013; 13: 349-361.
16. Loschen G, Azzi A, Richter C, Flohe L,. Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Lett 1974; 42: 68-72.
17. Boveris A, Cadenas E,. Mitochondrial production of superoxide anions and its relationship to the antimycin insensitive respiration. FEBS Lett 1975; 54: 311-314.
18. Imlay JA,. Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem 2008; 77: 755-776.
19. Bedard K, Krause KH,. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
20. Beckman JS, Koppenol WH,. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996; 271: C1424-C1437.
21. Radi R, Cassina A, Hodara R,. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 2002; 383: 401-409.
22. Holmgren A, Lu J,. Thioredoxin and thioredoxin reductase: Current research with special reference to human disease. Biochem Biophys Res Commun 2010; 396: 120-124.
23. O'Donnell-Tormey J, Nathan CF, Lanks K, DeBoer CJ, de la Harpe J,. Secretion of pyruvate. An antioxidant defense of mammalian cells. J Exp Med 1987; 165: 500-514.
24. Wedmann R, Bertlein S, Macinkovic I, et al. Working with "H2S": Facts and apparent artifacts. Nitric Oxide 2014; 41: 85-96.
25. Filipovic MR, Miljkovic J, Allgauer A, et al. Biochemical insight into physiological effects of H(2)S: Reaction with peroxynitrite and formation of a new nitric oxide donor, sulfinyl nitrite. Biochem J 2012; 441: 609-621.
26. Kovac S, Angelova PR, Holmstrom KM, Zhang Y, Dinkova-Kostova AT, Abramov AY,. Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochim Biophys Acta 2015; 1850: 794-801.
27. Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F,. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 1998; 91: 484-490.
28. Ferroni P, Vazzana N, Riondino S, Cuccurullo C, Guadagni F, Davi G,. Platelet function in health and disease: From molecular mechanisms, redox considerations to novel therapeutic opportunities. Antioxid Redox Signal 2012; 17: 1447-1485.
29. Krotz F, Sohn HY, Gloe T, et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 2002; 100: 917-924.
30. Chen S, Su Y, Wang J,. ROS-mediated platelet generation: A microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation. Cell Death Dis 2013; 4: e722-e722.
31. Wachowicz B, Olas B, Zbikowska HM, Buczynski A,. Generation of reactive oxygen species in blood platelets. Platelets 2002; 13: 175-182.
32. Begonja AJ, Gambaryan S, Geiger J, et al. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood 2005; 106: 2757-2760.
33. Duchez AC, Boudreau LH, Bollinger J, et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc Natl Acad Sci USA 2015; 112: E3564-E3573.
34. Boudreau LH, Duchez AC, Cloutier N, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 2014; 124: 2173-2183.
35. Krotz F, Sohn HY, Pohl U,. Reactive oxygen species: Players in the platelet game. Arterioscler Thromb Vasc Biol 2004; 24: 1988-1996.
36. Harris C, Hansen JM,. Oxidative stress, thiols, and redox profiles. Methods Mol Biol 2012; 889: 325-346.
37. Guo Z, Deshpande R, Paull TT,. ATM activation in the presence of oxidative stress. Cell Cycle 2010; 9: 4805-4811.
38. Cosentino C, Grieco D, Costanzo V,. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 2011; 30: 546-555.
39. Janko C, Filipovic M, Munoz LE, et al. Redox modulation of HMGB1-related signaling. Antioxid Redox Signal 2014; 20: 1075-1085.
40. Park S, Lippard SJ,. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA. Biochemistry 2011; 50: 2567-3574.
41. Marnett LJ,. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361-370.
42. Petrosillo G, Ruggiero FM, Paradies G,. Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J 2003; 17: 2202-2208.
43. Rothe T, Gruber F, Uderhardt S, et al. 12/15-Lipoxygenase-mediated enzymatic lipid oxidation regulates DC maturation and function. J Clin Invest 2015; 125: 1944-1954.
44. Kronke G, Katzenbeisser J, Uderhardt S, et al. 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. J Immunol 2009; 183: 3383-3389.
45. Ames BN,. Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun 1989; 7: 121-128.
46. Beckman KB, Ames BN,. Oxidative decay of DNA. J Biol Chem 1997; 272: 19633-19636.
47. Irwin DC, McCord JM, Nozik-Grayck E, et al. A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. Free Radic Biol Med 2009; 47: 55-61.
48. Shepherd VL,. The role of the respiratory burst of phagocytes in host defense. Semin Respir Infect 1986; 1: 99-106.
49. Kaplan MJ, Radic M,. Neutrophil extracellular traps: Double-edged swords of innate immunity. J Immunol 2012; 189: 2689-2695.
50. Zawrotniak M, Rapala-Kozik M,. Neutrophil extracellular traps (NETs)-formation and implications. Acta Biochim Pol 2013; 60: 277-284.
51. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A,. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 2010; 191: 677-691.
52. Akong-Moore K, Chow OA, von Kockritz-Blickwede M, Nizet V,. Influences of chloride and hypochlorite on neutrophil extracellular trap formation. PLoS One 2012; 7: e42984-e42984.
53. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E,. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 2004; 172: 2522-2529.
54. Sanlioglu S, Williams CM, Samavati L, et al. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem 2001; 276: 30188-30198.
55. Kang JL, Go YH, Hur KC, Castranova V,. Silica-induced nuclear factor-kappaB activation: Involvement of reactive oxygen species and protein tyrosine kinase activation. J Toxicol Environ Health A 2000; 60: 27-46.
56. Koay MA, Christman JW, Segal BH, et al. Impaired pulmonary NF-kappaB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice. Infect Immun 2001; 69: 5991-5996.
57. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H,. Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 2005; 7: 395-403.
58. Ogura M, Kitamura M,. Oxidant stress incites spreading of macrophages via extracellular signal-regulated kinases and p38 mitogen-activated protein kinase. J Immunol 1998; 161: 3569-3574.
59. Torres M, Forman HJ,. Activation of several MAP kinases upon stimulation of rat alveolar macrophages: Role of the NADPH oxidase. Arch Biochem Biophys 1999; 366: 231-239.
60. Ha YJ, Seul HJ, Lee JR,. Ligation of CD40 receptor in human B lymphocytes triggers the 5-lipoxygenase pathway to produce reactive oxygen species and activate p38 MAPK. Exp Mol Med 2011; 43: 101-110.
61. Lee JR, Koretzky GA,. Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur J Immunol 1998; 28: 4188-4197.
62. Volkman DJ, Buescher ES, Gallin JI, Fauci AS,. B cell lines as models for inherited phagocytic diseases: Abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome. J Immunol 1984; 133: 3006-3009.
63. Suzuki Y, Ohsugi K, Ono Y,. Oxidative stress triggers tyrosine phosphorylation in B cells through a redox- and inflammatory cytokine-sensitive mechanism. Immunology 1996; 87: 396-401.
64. Han W, Takano T, He J, et al. Role of BLNK in oxidative stress signaling in B cells. Antioxid Redox Signal 2001; 3: 1065-1073.
65. Singh DK, Kumar D, Siddiqui Z, Basu SK, Kumar V, Rao KV,. The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal. Cell 2005; 121: 281-293.
66. Capasso M, Bhamrah MK, Henley T, et al. HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat Immunol 2010; 11: 265-272.
67. Crotzer VL, Matute JD, Arias AA, et al. Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B cells. J Immunol 2012; 189: 3800-3804.
68. Cotugno N, Finocchi A, Cagigi A, et al. Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease. J Allergy Clin Immunol 2015; 135: 753-761 e2.
69. Moir S, De Ravin SS, Santich BH, et al. Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cells. Blood 2012; 120: 4850-4858.
70. Chaudhri G, Hunt NH, Clark IA, Ceredig R,. Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell Immunol 1988; 115: 204-213.
71. Sena LA, Li S, Jairaman A, et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 2013; 38: 225-236.
72. Cemerski S, Cantagrel A, Van Meerwijk JP, Romagnoli P,. Reactive oxygen species differentially affect T cell receptor-signaling pathways. J Biol Chem 2002; 277: 19585-19593.
73. Flescher E, Ledbetter JA, Schieven GL, et al. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J Immunol 1994; 153: 4880-4889.
74. Efimova O, Szankasi P, Kelley TW,. Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells. PLoS One 2011; 6: e16013-e16013.
75. Shatynski KE, Chen H, Kwon J, Williams MS,. Decreased STAT5 phosphorylation and GATA-3 expression in NOX2-deficient T cells: role in T helper development. Eur J Immunol 2012; 42: 3202-3211.
76. Takahashi A, Hanson MG, Norell HR, et al. Preferential cell death of CD8+ effector memory (CCR7-CD45RA-) T cells by hydrogen peroxide-induced oxidative stress. J Immunol 2005; 174: 6080-6087.
77. Mougiakakos D, Johansson CC, Kiessling R,. Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death. Blood 2009; 113: 3542-3545.
78. Bogeski I, Kummerow C, Al-Ansary D, et al. Differential redox regulation of ORAI ion channels: A mechanism to tune cellular calcium signaling. Sci Signal 2010; 3: ra24-ra24.
79. Bridges RA, Berendes H, Good RA,. A fatal granulomatous disease of childhood: The clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child 1959; 97: 387-408.
80. Winkelstein JA, Marino MC, Johnston RB Jr., et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79: 155-169.
81. Baehner RL, Karnovsky ML,. Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease. Science 1968; 162: 1277-1279.
82. van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: The European experience. PLoS One 2009; 4: e5234-e5234.
83. Flannagan RS, Cosio G, Grinstein S,. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 2009; 7: 355-366.
84. Bleesing JJ, Souto-Carneiro MM, Savage WJ, et al. Patients with chronic granulomatous disease have a reduced peripheral blood memory B cell compartment. J Immunol 2006; 176: 7096-7103.
85. Wheeler ML, Defranco AL,. Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation. J Immunol 2012; 189: 4405-4416.
86. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J,. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
87. De Ravin SS, Naumann N, Cowen EW, et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol 2008; 122: 1097-1103.
88. Narsipur SS, Shanley PF,. IgA nephropathy in a patient with chronic granulomatous disease. J Nephrol 2002; 15: 713-715.
89. Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004; 114: 462-468.
90. Lee BW, Yap HK,. Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. Arthritis Rheum 1994; 37: 773-776.
91. Manzi S, Urbach AH, McCune AB, et al. Systemic lupus erythematosus in a boy with chronic granulomatous disease: Case report and review of the literature. Arthritis Rheum 1991; 34: 101-105.
92. Cobeta-Garcia JC, Domingo-Morera JA, Monteagudo-Saez I, Lopez-Longo FJ,. Autosomal chronic granulomatous disease and systemic lupus erythematosus with fatal outcome. Br J Rheumatol 1998; 37: 109-111.
93. Johnson AE, Gordon C, Palmer RG, Bacon PA,. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38: 551-558.
94. Ramos PS, Brown EE, Kimberly RP, Langefeld CD,. Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol 2010; 30: 164-176.
95. Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L,. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol 2009; 30: 455-464.
96. Aranow C, Ginzler EM,. Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 2000; 9: 166-169.
97. Cai H, Harrison DG,. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000; 87: 840-844.
98. Virdis A, Tani C, Duranti E, et al. Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus. Arthritis Res Ther 2015; 17: 277-277.
99. Morgan PE, Sturgess AD, Davies MJ,. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res 2009; 43: 117-127.
100. Morgan PE, Sturgess AD, Davies MJ,. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 2069-2079.
101. Khan F, Siddiqui AA, Ali R,. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus. Scand J Immunol 2006; 64: 507-514.
102. Olofsson P, Holmberg J, Pettersson U, Holmdahl R,. Identification and isolation of dominant susceptibility loci for pristane-induced arthritis. J Immunol 2003; 171: 407-416.
103. Hultqvist M, Olofsson P, Gelderman KA, Holmberg J, Holmdahl R,. A new arthritis therapy with oxidative burst inducers. PLoS Med 2006; 3: e348-e348.
104. Backlund J, Nandakumar KS, Bockermann R, Mori L, Holmdahl R,. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model. J Immunol 2003; 171: 3493-3499.
105. Olsson LM, Lindqvist AK, Kallberg H, et al. A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res Ther 2007; 9: R98-R98.
106. Bohanec Grabar P, Logar D, Tomsic M, Rozman B, Dolzan V,. Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients. Dis Markers 2009; 26: 41-48.
107. Olsson LM, Nerstedt A, Lindqvist AK, et al. Copy number variation of the gene NCF1 is associated with rheumatoid arthritis. Antioxid Redox Signal 2012; 16: 71-78.
108. Cerhan JR, Saag KG, Merlino LA, Mikuls TR, Criswell LA,. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 2003; 157: 345-354.
109. Greenwald RA, Moy WW,. Inhibition of collagen gelation by action of the superoxide radical. Arthritis Rheum 1979; 22: 251-259.
110. Monboisse JC, Braquet P, Randoux A, Borel JP,. Non-enzymatic degradation of acid-soluble calf skin collagen by superoxide ion: Protective effect of flavonoids. Biochem Pharmacol 1983; 32: 53-58.
111. Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, Galdo F,. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum 1998; 41: 284-289.
112. Del Carlo M Jr., Loeser RF,. Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum 2002; 46: 394-403.
113. Tiku ML, Shah R, Allison GT,. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 2000; 275: 20069-20076.
114. Tiku ML, Gupta S, Deshmukh DR,. Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic Res 1999; 30: 395-405.
115. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J,. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-241.
116. Schorn C, Frey B, Lauber K, et al. Sodium overload and water influx activate the NALP3 inflammasome. J Biol Chem 2011; 286: 35-41.
117. Maueroder C, Kienhofer D, Hahn J, et al. How neutrophil extracellular traps orchestrate the local immune response in gout. J Mol Med (Berl) 2015; 93: 727-734.
118. Scanu A, Oliviero F, Ramonda R, Frallonardo P, Dayer JM, Punzi L,. Cytokine levels in human synovial fluid during the different stages of acute gout: Role of transforming growth factor beta1 in the resolution phase. Ann Rheum Dis 2012; 71: 621-624.
119. Zakkar M, Van der Heiden K, Luong le A, et al. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol 2009; 29: 1851-1857.
120. Bosmann M, Ward PA,. The inflammatory response in sepsis. Trends Immunol 2013; 34: 129-136.
121. Creager MA, Luscher TF, Cosentino F, Beckman JA,. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003; 108: 1527-1532.
122. Giugliano D, Ceriello A, Paolisso G,. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
123. Brownlee M,. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
124. Karima M, Kantarci A, Ohira T, et al. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol 2005; 78: 862-870.
125. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR,. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996; 90: 255-260.
126. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C,. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003; 34: 1563-1574.
127. Jachec W, Tomasik A, Tarnawski R, Chwalinska E,. Evidence of oxidative stress in the renal cortex of diabetic rats: Favourable effect of vitamin E. Scand J Clin Lab Invest 2002; 62: 81-88.
128. Tagami S, Kondo T, Yoshida K, Hirokawa J, Ohtsuka Y, Kawakami Y,. Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits. Metabolism 1992; 41: 1053-1058.
129. Sailaja YR, Baskar R, Saralakumari D,. The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics. Free Radic Biol Med 2003; 35: 133-139.
130. Chari SN, Nath N, Rathi AB,. Glutathione and its redox system in diabetic polymorphonuclear leukocytes. Am J Med Sci 1984; 287: 14-15.
131. Haskins K, Bradley B, Powers K, et al. Oxidative stress in type 1 diabetes. Ann NY Acad Sci 2003; 1005: 43-54.